Moleac at the 26th European Stroke Conference

By May 26, 2017News

Moleac team just attended the 26th European Stroke Conference (ESC) in Berlin, Germany in the past 3 days.

Research on NeuroAiD remains highly active and international conferences are great opportunities to present the latest findings from clinical trials and studies. This year, in addition to new data on the benefits for post-stroke recovery, clinicians presented new insights from NeuroAiD studies targeted at stroke victims with high potential for recovery:

  • Comparison of Long-term Spontaneous Functional Recovery and Response to Treatment with MLC601 between Cortical and Non-cortical strokes – The CHIMES-E study
  • Synergistic Effect of Combining MLC601 and Rehabilitation on Post-stroke Recovery – The CHIMES Study
  • Targeting Stroke Patients with a Higher Potential of Long-term Benefit from Treatment: Insights from the CHIMES-E Study

On 25th May, we were overwhelmed to have a full house of 50 people attending our dinner symposium at Swissotel Berlin.  It was our honour to listen to presentations from world-class leaders in stroke research:

  • Prof. Tatjana Rundek from the Unites States presented her work on long-term prognosis and outcome of patients after stroke.
  • Prof. Michel Lazdunski from France, who has conducted several important preclinical studies on NeuroAiD with his team, presented neurorestorative strategies from natural substances.
  • Prof. N Venketasubramanian (Ramani) from Singapore, one of the principal investigators of NeuroAiD’s landmark studies, presented CHIMES and CHIMES-E key outcomes NeuroAiD clinical benefit on post-stroke recovery and insights regarding patients’ selection for clinical research.

We look forward to replicating such a success next year.